Defibrotide combined with triple therapy including posttransplant cyclophosphamide, low dose rabbit anti-t-lymphocyte globulin and cyclosporine is effective in prevention of graft versus host disease after allogeneic peripheral blood stem cell transplantation for hematologic malignancies
-
Published:2022-02
Issue:1
Volume:61
Page:103367
-
ISSN:1473-0502
-
Container-title:Transfusion and Apheresis Science
-
language:en
-
Short-container-title:Transfusion and Apheresis Science
Author:
Akpinar SevalORCID,
Kayikci Omur,
Tekgunduz Emre
Reference39 articles.
1. State-of-the-art acute and chronic GVHD treatment;Jamil;Int J Hematol,2015
2. Posttransplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EMBT;Sanz;J Hematol Oncol,2021
3. Haploidentical stem cell transplantation with posttransplant cyclophosphamide therapy vs other donor transplantations in adults with hematologic cancers a systematic review and meta-analysis;Gagelmann;JAMA Oncol,2019
4. Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation;Al Malki;Blood Adv,2020
5. Single-agent GVHD prophylaxis with posttransplant cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS;Kanakry;Blood,2014
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献